What is the recommended ceftriaxone dose for treating wound infections in adults (including severe cases) and children, and how should the dose be adjusted for renal or hepatic impairment?

Ceftriaxone Dosing for Wound Infections

For wound infections in adults, use ceftriaxone 1-2 g IV every 24 hours, with 1 g every 12 hours recommended for animal/human bites; in children, use 50-75 mg/kg/day (maximum 2 g/day) given once daily or divided every 12 hours. 1, 2

Adult Dosing

Standard Wound Infections

• 1-2 g IV once daily is the standard dose for most skin and soft tissue infections 1, 2
• The once-daily regimen is effective due to ceftriaxone's long half-life (5.8-8.7 hours) and high protein binding 2
• Clinical cure rates of 81% have been demonstrated with 1 g daily for serious skin and soft tissue infections 3

Severe/Necrotizing Infections

For life-threatening necrotizing infections involving specific pathogens:

• Aeromonas hydrophila: 1-2 g IV every 24 hours (combined with doxycycline) 1
• Vibrio vulnificus: 1 g IV four times daily OR 2 g three times daily (combined with doxycycline) 1

Bite Wounds (Animal/Human)

• 1 g IV every 12 hours as an alternative agent 1
• Ceftriaxone provides good activity against Pasteurella multocida but misses anaerobes and MRSA 1
• Consider combination therapy for comprehensive coverage

Pediatric Dosing

Standard Infections

• 50-75 mg/kg/day given once daily or divided every 12 hours 2
• Maximum daily dose: 2 grams 2
• Once-daily dosing provides equal efficacy to divided doses with greater ease of administration 4

Severe Infections (Non-Meningitis)

• 50-75 mg/kg/day in divided doses every 12 hours 2
• Maximum 2 g/day 2

Meningitis

• Initial dose: 100 mg/kg (not to exceed 4 g) 2
• Maintenance: 100 mg/kg/day (maximum 4 g/day) once daily or divided every 12 hours 2

Administration in Neonates

• Administer over 60 minutes (not 30 minutes) to reduce risk of bilirubin encephalopathy 2
• Contraindicated in hyperbilirubinemic neonates, especially prematures 2
• Contraindicated in neonates ≤28 days requiring calcium-containing IV solutions 2

Renal Impairment Adjustments

No dose adjustment is necessary for renal impairment alone 2, 5, 6

The rationale:

• 30-60% of ceftriaxone is eliminated via biliary mechanisms (non-renal) 5
• In functionally anephric patients with normal liver function, half-life increases only modestly (to ~12 hours vs. 8 hours normally) 5
• Even with creatinine clearance <15 mL/min, mean half-life is 15.6 hours, and standard dosing (1 g every 24 hours) maintains adequate plasma concentrations 6
• Ceftriaxone is not significantly removed by hemodialysis 2

Exception

Dose adjustment may be needed only in anephric patients with concurrent severe hepatic dysfunction (>80% decrease in non-renal elimination), where half-life exceeds 15 hours 5

Hepatic Impairment Adjustments

No dose adjustment necessary for hepatic impairment alone 2, 5

Key considerations:

• Patients with liver cirrhosis without ascites show no significant pharmacokinetic changes 5
• Patients with ascites show altered clearance and volume of distribution, but half-life remains similar (9.7 hours vs. 8 hours) 5
• Maximum dose should not exceed 2 g/day in patients with combined severe renal and hepatic impairment 2

Recent Pharmacokinetic Insights

A 2026 population pharmacokinetics study 7 suggests that once-daily regimens may be inadequate in patients with preserved or augmented renal function (eGFR ≥60 mL/min/1.73 m²). The study recommends:

• eGFR >60 mL/min/1.73 m²: 1 g every 12 hours
• eGFR ≤60 mL/min/1.73 m²: 1 g every 24 hours

This challenges traditional dosing but aligns with the IDSA guideline's option for twice-daily dosing in bite wounds 1.

Administration Guidelines

Intravenous

• Infuse over 30 minutes in adults and children (except neonates) 2
• Concentrations of 10-40 mg/mL are recommended 2

Intramuscular

• Can be used for outpatient or step-down therapy 2
• Inject deeply into large muscle mass 2

Critical Warnings

• Never mix with calcium-containing solutions (risk of precipitation) 2
• In non-neonates, calcium-containing solutions may be given sequentially if lines are thoroughly flushed 2

Duration of Therapy

• Continue for at least 2 days after signs/symptoms resolve 2
• Usual duration: 4-14 days; complicated infections may require longer 2
• For Streptococcus pyogenes infections: minimum 10 days 2

Clinical Pearls

• Polymicrobial infections: Ceftriaxone shows superior outcomes compared to cefazolin (0 failures in 12 patients vs. 5 failures in 13 patients) 3
• Dose consolidation: The nonlinear protein binding favors large single doses over divided doses 5
• Lower doses for pneumonia: Recent data suggests 1 g/day may be sufficient for community-acquired pneumonia with similar mortality and lower C. difficile rates 8, though wound infections may require higher dosing for adequate tissue penetration